Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study.
Journal of the National Cancer Institute.
Times cited: 75
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study.
Times cited: 119
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: The PROBASE trial.
Times cited: 23